Taken together, our results indicate that miR-142 targets TIM-1, representing a novel strategy against cerebrovascular disorders, as well as systemic complications of SARS-CoV-2 and other viral infections. This evidence concerns the gene HAVCR1 and cerebrovascular disorder.